E&C Considers Bill Requiring FDA Swiftly Allow Alternatives To Animal Testing

The House Energy & Commerce Committee will consider bipartisan legislation Thursday (Feb. 29) that would mandate FDA implement within 180 days a 2022 law that allows drug sponsors to use alternatives to animal testing, coming amid growing frustration by lawmakers that the agency hasn’t updated its guidance to reflect the 2022 law. The new bill, the FDA Modernization Act 3.0 (FDAMA 3.0) or H.R. 7248 , was introduced earlier this month in a bid to force the agency to implement...